View in EDS HTML Full Text PDF Full Text

Ado-trastuzumab for the treatment of metastatic HER2-positive breast cancer in patients previously treated with Pertuzumab.

Saved in:
Bibliographic Details
Title: Ado-trastuzumab for the treatment of metastatic HER2-positive breast cancer in patients previously treated with Pertuzumab.
Authors: Al Rabadi LS; Knight Cancer Institute, Oregon Health & Science University, 3181 SW Sam Jackson Road, OC14HO, Portland, OR, 97239, USA., Cook MM; School of Medicine, Oregon Health & Science University, Portland, OR, USA., Kaempf AJ; Knight Cancer Institute, Biostatistics Shared Resource, Oregon Health & Science University, Portland, OR, USA., Saraceni MM; Department of Pharmacy, Oregon Health & Science University, Portland, OR, USA., Savin MA; Knight Cancer Institute, Oregon Health & Science University, 3181 SW Sam Jackson Road, OC14HO, Portland, OR, 97239, USA., Mitri ZI; Knight Cancer Institute, Oregon Health & Science University, 3181 SW Sam Jackson Road, OC14HO, Portland, OR, 97239, USA. mitri@ohsu.edu.
Source: BMC cancer [BMC Cancer] 2021 Oct 27; Vol. 21 (1), pp. 1150. Date of Electronic Publication: 2021 Oct 27.
Publication Type: Journal Article
Journal Info: Publisher: BioMed Central Country of Publication: England NLM ID: 100967800 Publication Model: Electronic Cited Medium: Internet ISSN: 1471-2407 (Electronic) Linking ISSN: 14712407 NLM ISO Abbreviation: BMC Cancer Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 34706686
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Ado-trastuzumab for the treatment of metastatic HER2-positive breast cancer in patients previously treated with Pertuzumab.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Al+Rabadi+LS%22">Al Rabadi LS</searchLink>; Knight Cancer Institute, Oregon Health & Science University, 3181 SW Sam Jackson Road, OC14HO, Portland, OR, 97239, USA.<br /><searchLink fieldCode="AU" term="%22Cook+MM%22">Cook MM</searchLink>; School of Medicine, Oregon Health & Science University, Portland, OR, USA.<br /><searchLink fieldCode="AU" term="%22Kaempf+AJ%22">Kaempf AJ</searchLink>; Knight Cancer Institute, Biostatistics Shared Resource, Oregon Health & Science University, Portland, OR, USA.<br /><searchLink fieldCode="AU" term="%22Saraceni+MM%22">Saraceni MM</searchLink>; Department of Pharmacy, Oregon Health & Science University, Portland, OR, USA.<br /><searchLink fieldCode="AU" term="%22Savin+MA%22">Savin MA</searchLink>; Knight Cancer Institute, Oregon Health & Science University, 3181 SW Sam Jackson Road, OC14HO, Portland, OR, 97239, USA.<br /><searchLink fieldCode="AU" term="%22Mitri+ZI%22">Mitri ZI</searchLink>; Knight Cancer Institute, Oregon Health & Science University, 3181 SW Sam Jackson Road, OC14HO, Portland, OR, 97239, USA. mitri@ohsu.edu.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22100967800%22">BMC cancer</searchLink> [BMC Cancer] 2021 Oct 27; Vol. 21 (1), pp. 1150. <i>Date of Electronic Publication: </i>2021 Oct 27.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22BioMed+Central%22">BioMed Central </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>100967800 <i>Publication Model: </i>Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1471-2407 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2214712407%22">14712407 </searchLink><i>NLM ISO Abbreviation: </i>BMC Cancer <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=34706686
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1186/s12885-021-08894-2
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 1150
    Titles:
      – TitleFull: Ado-trastuzumab for the treatment of metastatic HER2-positive breast cancer in patients previously treated with Pertuzumab.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Al Rabadi LS
      – PersonEntity:
          Name:
            NameFull: Cook MM
      – PersonEntity:
          Name:
            NameFull: Kaempf AJ
      – PersonEntity:
          Name:
            NameFull: Saraceni MM
      – PersonEntity:
          Name:
            NameFull: Savin MA
      – PersonEntity:
          Name:
            NameFull: Mitri ZI
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 27
              M: 10
              Text: 2021 Oct 27
              Type: published
              Y: 2021
          Identifiers:
            – Type: issn-electronic
              Value: 1471-2407
          Numbering:
            – Type: volume
              Value: 21
            – Type: issue
              Value: 1
          Titles:
            – TitleFull: BMC cancer
              Type: main
ResultId 1